The GMRF Clinical Trials Unit has two liver clinical trials recruiting. PROTOCOL: 337HNAS20011 (NATiV3) (PI: DR Darrell Crawford) Protocol Title: A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment...
The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in general oncology: PROTOCOL: NST-628-001 (PI: Dt Victoria Atkinson) (NOT YET RECRUITING) Protocol Title: A Phase 1, open label single-arm two-part study to investigate safety, pharmacokinetics, and preliminary...
Currently recruiting gastro-intestinal trials Protocol: AMP945-PC-201 (PI: Dr Warren Joubert) Protocol Title: A Phase 1b/2a, Multicentre, Open Label Study of the Pharmacokinetics, Safety and Efficacy of AMP945 in Combination with Nab-paclitaxel and Gemcitabine in Pancreatic Cancer Patients Lay Title:...
The GMRF Clinical Trials Unit will soon be recruiting for the following lung clinical trial: Protocol: GO45006 (PI: Professor Kenneth O'Byrne) (NOT YET RECRUITING) Protocol Title: Study Title: A Phase III, Randomized, Double-Blinded, Placebo-Controlled Study of Tiragolumab, an Anti-Tigit Antibody,...
The GMRF Clinical Trials Unit is currently recruiting for the following melanoma trials: PROTOCOL: IMC-F106C-301 (PI: Professor Victoria Atkinson) Protocol Title: A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants...
The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in genitourinary cancer: PROTOCOL: BGB-A317-3111-10188-101 (PI: Jeffrey Goh) (PART E (OVARIAN) ONLY) Protocol Title: A Phase 1/2, Dose Escalation and Expansion Study of BGB-10188, a Phosphatidylinositol 3-Kinase...
The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in Haematology: PROTOCOL: CA058-1019 (PI: Doctor Nathan Klose) Protocol Title: A Phase 3, Randomized, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens...
The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in respiratory illness: PROTOCOL: EBO-301 (MACrO2) (PI: DR RACHEL THOMSON) (ON HOLD) Protocol Title: A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy,...
There are no studies currently recruiting for infectious diseases